This media is not supported in your browser
VIEW IN TELEGRAM
This media is not supported in your browser
VIEW IN TELEGRAM
This media is not supported in your browser
VIEW IN TELEGRAM
This media is not supported in your browser
VIEW IN TELEGRAM
This media is not supported in your browser
VIEW IN TELEGRAM
This media is not supported in your browser
VIEW IN TELEGRAM
This media is not supported in your browser
VIEW IN TELEGRAM
This media is not supported in your browser
VIEW IN TELEGRAM
This media is not supported in your browser
VIEW IN TELEGRAM
Winter in Switzerland🇨🇭
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
Article
Article
The New England Journal of Medicine
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients | NEJM
Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe
coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic,
nonhospitalized patients wi...
coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic,
nonhospitalized patients wi...
This media is not supported in your browser
VIEW IN TELEGRAM
Regular Sunday on the Harmony of the Seas cruise ship
Forwarded from Dschlopes
This media is not supported in your browser
VIEW IN TELEGRAM
This is very important understand from Dr. McCullough:
Early treatment has ALWAYS shown tremendous success against Covid.
The intentional sabotage of effective early treatment is the biggest thing that the retreating enemy does not want people talking about or looking into...
Even more than US/China Gain of Function research.
@Dschlopes
Early treatment has ALWAYS shown tremendous success against Covid.
The intentional sabotage of effective early treatment is the biggest thing that the retreating enemy does not want people talking about or looking into...
Even more than US/China Gain of Function research.
@Dschlopes
🔥2